News

Time Magazine's Best Inventions of 2020 (Our Client CrazyCap TM)

November 25, 2020

“When people want clean water, they reach for plastic bottles,” says CrazyCap CEO Rakesh Guduru. “It’s bad for your health and the environment.” For those who want a more sustainable way to hydrate on the go, Guduru created a bottle cap that uses UVC light to sanitize water in just 60 seconds. The device has two modes, one to purify water from taps or public fountains, the other for...

See More

WE HAVE MOVED!

April 25, 2018

Our office has moved locations. For the last year, we’ve been working with a team of architects and workplace designers to create and deliver

See More

Patent Owner's Successful Argument in Prosecution Helps PTAB Reject Live Nation's Bid for PGR.

February 1, 2018

Weiss & Arons LLP successfully prosecuted a patent application for Complete Entertainment Resources ("CER") (U.S Patent No. 9,466,035). After being hit with an anti-trust suit by CER, Live Nation retaliated with a Post Grant Review (PGR) of the CER patent.  But the PTAB denied Live Nation's bid, because the examiner rejected very similar arguments during the prosecution of the CER...

See More

Reversed Refusal and Obtained Registration of Four Trademarks

December 5, 2017

Weiss & Arons’ partner Abigail Rubinstein Esq. prevailed in an appeal to the Trademark Trial and Appeal Board after refusal of four trademark registrations on the basis of descriptiveness. The Examining Attorney withdrew refusals of two of the marks after considering Weiss & Arons’ appeal briefs. The Board agreed with our arguments that the Examiner’s evidence did not support a...

See More

Patent Owner Preliminary Responses to Inter Partes Review Petitions Lead to Termination of PTAB Proceedings Initiated by Edwards Lifesciences

June 23, 2016

Weiss & Arons, LLP, prosecuted a patent application for Endoheart AG's transapical TAVI valve replacement method, and obtained U.S. Patent No. 8,182,530, which Endoheart AG then asserted against Edwards Lifesciences in the Federal District Court for the District of Delaware.  Defendant Edwards Lifesciences filed two requests for Inter Partes Review in the U.S. Patent and Trademark...

See More